Clinical Practice Recommendations on Kidney Management in Methylmalonic Acidemia: an Expert Consensus Statement From ERKNet and MetabERN
2024

Kidney Management Guidelines for Methylmalonic Acidemia

publication Evidence: moderate

Author Information

Author(s): Servais Aude, Zacchia Miriam, Dehoux Laurène, Shroff Rukshana, Brassier Anais, Taurisano Roberta, Kölker Stefan, Oh Jun, Ariceta Gema, Stojanovic Jelena, Hörster Friederike, Strologo Dello, Spada Marco, Schiff Manuel, Dionisi-Vici Carlo

Primary Institution: Nephrology and Transplantation Department, Inherited Kidney Diseases Reference Center, Necker-Enfants Malades University Hospital, Assistance Publique Hôpitaux de Paris, Inserm U1163, Imagine Institute, Université de Paris, Paris, France

Hypothesis

The guidelines aim to provide clinical practice recommendations for kidney management in patients with methylmalonic acidemia (MMA).

Conclusion

The guidelines produced 13 statements to guide the management of chronic kidney disease, dialysis, and transplantation in patients with MMA.

Supporting Evidence

  • Chronic kidney disease is a common complication in patients with methylmalonic acidemia.
  • Creatinine-based formulas overestimate kidney function in these patients.
  • Long-term dialysis may be necessary for clearance of toxic metabolites.

Takeaway

Doctors created a set of rules to help treat kids and adults with a rare disease that affects their kidneys. These rules will help them manage kidney problems better.

Methodology

The guidelines were developed through a systematic literature review and expert consensus involving pediatric and adult nephrologists, metabolic specialists, and transplant surgeons.

Potential Biases

Potential bias may arise from the expert panel's perspectives and the selection of literature reviewed.

Limitations

The recommendations are based on expert opinion and existing literature, which may not cover all aspects of patient care.

Participant Demographics

The guidelines consider both pediatric and adult patients with methylmalonic acidemia.

Digital Object Identifier (DOI)

10.1016/j.ekir.2024.09.002

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication